Trial
NCT00177970
IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Pittsburgh
Collaborators
Shadyside Hospital Foundation; Bayer
Condition
Clostridium Difficile-associated Diarrhea (CDAD)
Intervention
intravenous immunoglobulin G (IVIG)
Why stopped
We were unable to receive IVIG free from phamaceutical company.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-25